Article

Seattle Times on 2022-02-03 13:15

Merck has strong fourth quarter as COVID-19 treatment debuts

The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker’s COVID-19 treatment debuted with nearly $1 ...

Related news

Merck has strong quarter even as COVID-19 treatment tumble seattletimes.com
Rahway , United Kingdom
Merck posts strong first-quarter profit, but revenue light apnews.com
New Jersey , Wall Street , Japan , Kenilworth
APepsiCo puts up strong numbers in fourth quarter apnewsarchive.com
New York , Wall Street
AA strong 2Q for Merck, outlook mixed apnewsarchive.com
New Jersey , Wall Street , Kenilworth
Coca-Cola overcomes falling demand in North America and puts up strong fourth quarter sales apnews.com
Wall Street , Atlanta , New York , Pittsburgh , Germany
Home Depot’s strong fourth quarter overshadowed by weakening sales and expectations for 2024 Seattle Times
Atlanta , Wall Street
BMicrosoft Rises on Strong Fourth-Quarter Earnings barrons.com
Wall Street
Best Buy posts strong fourth-quarter sales finance-commerce.com
China , Richfield , Wall Street
Merck 4Q powered by cancer treatment sales bradenton.com
New Jersey , Kenilworth
Merck shares soar along with its first quarter profit Seattle Times
New Jersey , China , Wall Street , Kenilworth
Merck profits reach $687M in second quarter The Salt Lake Tribune
Wall Street , Kenilworth
Merck expects brunt of pandemic will strike this quarter journalrecord.com
Wall Street , New Jersey , Kenilworth
Merck posts global sales of $11B in third quarter The Wichita Eagle
China , Europe , New Jersey , Wall Street , Kenilworth
HA Strong 2Q for Merck, Outlook Mixed hamodia.com
United Kingdom , New Jersey , Wall Street